Browse the corpus

REFERENCES American Dental Association Council on Scientific Affairs, “Dental Management of Patients Receiving Oral Bisphosphonate Therapy: Expert Panel Recommendations,” J Am Dent Assoc , 2006, 137(8):1144-50. Available at file://jada.ada.org/cgi/content/full/137/8/1144 [PubMed 16873332 ] Assael LA, “Oral Bisphosphonates as a Cause of Bisphosphonate-Related Osteonecrosis of the Jaws: Clinical Findings, Assessment of Risks, and Preventive Strategies,” J Oral Maxillofac Surg , 2009, 67(5 Suppl):35-43. [PubMed 19371813 ] Author Unknown, “Safety Update: Bone-Building Drugs: Risks Explained,” Consum Rep Health , 2006, 18(5):3. Cartsos VM, Zhu S, and Zavras AI, “Bisphosphonate Use and the Risk of Adverse Jaw Outcomes: A Medical Claims Study of 714,217 People,” J Am Dent Assoc , 2008, 139(1):23-30. [PubMed 18167381 ] Chesnut CH 3rd, McClung MR, Ensrud KE, et al, “Alendronate Treatment of the Postmenopausal Osteoporatic Woman: Effect of Multiple Dosages on Bone Mass and Bone Remodeling,” Am J Med , 1995, 99(2):144-52. [PubMed 7625419 ] Edwards BJ, Hellstein JW, Jacobsen PL, et al, “Updated Recommendations for Managing the Care of Patients Receiving Oral Bisphosphonate Therapy: An Advisory Statement From the American Dental Association Council on Scientific Affairs,” J Am Dent Assoc , 2008, 139(12):1674-7. [PubMed 19047674 ] Filleul O, Crompot E, and Saussez S, "Bisphosphonate-Induced Osteonecrosis of the Jaw: A Review of 2,400 Patient Cases," J Cancer Res Clin Oncol , 2010, 136(8):1117-24. [PubMed 20508948 ] French AE, Kaplan N, Lishner M, et al, “Taking Bisphosphonates During Pregnancy,” Can Fam Physician , 2003, 49:1281-2. [PubMed 14594094 ] Lo JC, O'Ryan FS, Gordon NP, et al, “Prevalence of Osteonecrosis of the Jaw in Patients With Oral Bisphosphonate Exposure,” J Oral Maxillofac Surg , 2010, 68(2):243-53. [PubMed 19772941 ] “Management of Osteoporosis in Postmenopausal Women: 2010 Position Statement of The North American Menopause Society,” Menopause , 2010, 17(1):25-54. [PubMed 20061894 ] Marx RE, Sawatari Y, Fortin M, et al, “Bisphosphonate-Induced Exposed Bone (Osteonecrosis/Osteopetrosis) of the Jaws: Risk Factors, Recognition, Prevention, and Treatment,” J Oral Maxillofac Surg , 2005, 63(11):1567-75. [PubMed 16243172 ]

“Management of Osteoporosis in Postmenopausal Women: 2010 Position Statement of The North American Menopause Society,” Menopause , 2010, 17(1):25-54. [PubMed 20061894 ] Marx RE, Sawatari Y, Fortin M, et al, “Bisphosphonate-Induced Exposed Bone (Osteonecrosis/Osteopetrosis) of the Jaws: Risk Factors, Recognition, Prevention, and Treatment,” J Oral Maxillofac Surg , 2005, 63(11):1567-75. [PubMed 16243172 ] Mavrokokki T, Cheng A, Stein B, et al, “Nature and Frequency of Bisphosphonate-Associated Osteonecrosis of the Jaws in Australia,” J Oral Maxillofac Surg , 2007, 65(3):415-23. [PubMed 17307586 ] National Osteoporosis Foundation, “Clinician’s Guide to Prevention and Treatment of Osteoporosis,” Washington, DC, 2010. Available at file://www.nof.org/files/nof/public/content/file/344/upload/159.pdf Orwoll E, Ettinger M, Weiss S, et al, “Alendronate for the Treatment of Osteoporosis in Men,” N Engl J Med , 2000, 343(9):604-10. [PubMed 10979796 ] Ralston SH, “Pathogenesis of Paget's Disease of Bone,” Bone , 2008, 43(5):819-25. [PubMed 18672105 ] Sellmeyer DE, “Atypical Fractures as a Potential Complication of Long-term Bisphosphonate Therapy,” JAMA , 2010, 304(13):1480-4. [PubMed 20924014 ] Shane E, Burr D, Ebeling PR, et al, “Atypical Subtrochanteric and Diaphyseal Femoral Fractures: Report of a Task Force of the American Society for Bone and Mineral Research,” J Bone Miner Res , 2010, 25(11):2267-94. [PubMed 20842676 ] Watts NB, “Treatment of Osteoporosis With Bisphosphonates,” Rheum Dis Clin North Am , 1994, 20(3):717-34. [PubMed 7984786 ] Whyte MP, “Clinical Practice. Paget's Disease of Bone,” N Engl J Med , 2006, 355(6):593-600. [PubMed 16899779 ] Wysowski DK, “Reports of Esophageal Cancer With Oral Bisphosphonate Use,” N Engl J Med , 2009, 360(1):89-90. [PubMed 19118315 ] Topic 9427 Version 47.0 © 2013 UpToDate, Inc. All rights reserved. | Subscription and License Agreement | Release: 21.6- C21.56 Licensed to: AsanBook Dig. Med. Lib. | Support Tag: [0503-61.234.146.186-DA858D2583-S244013.14]